Rockwell Medical (RMTI) Total Non-Current Liabilities (2010 - 2025)
Rockwell Medical (RMTI) reported Total Non-Current Liabilities of $20.2 million for Q4 2025, down 21.3% on a YoY basis from $25.6 million in Q4 2024, and down 1.48% quarter-over-quarter from $20.5 million in Q3 2025.
Rockwell Medical (RMTI) Total Non-Current Liabilities (2010 - 2025) Analysis & Trends
Rockwell Medical has reported Total Non-Current Liabilities for 11 years, with the latest figure at $20.2 million in Q4 2025.
- For the quarter ending Q4 2025, Total Non-Current Liabilities fell 21.3% year-over-year to $20.2 million; the trailing twelve-month figure through Dec 2025 stood at $20.2 million (down 21.3% YoY), and the FY2025 full-year result was $20.2 million, down 21.3% from the prior year.
- Total Non-Current Liabilities for Q4 2025 stood at $20.2 million, down from $20.5 million in the prior quarter.
- The five-year high for Total Non-Current Liabilities was $46.0 million in Q4 2021, with the low at $19.5 million in Q1 2025.
- Historically, Total Non-Current Liabilities has averaged $29.7 million across 5 years, with a median of $28.5 million in 2023.
- Annual changes were most pronounced in 2021 — Total Non-Current Liabilities advanced 5.62% — and 2023, when it sank 33.89%.
- Rockwell Medical's Total Non-Current Liabilities stood at $46.0 million in 2021, then slipped by 29.35% to $32.5 million in 2022, then fell by 5.07% to $30.9 million in 2023, then fell by 16.99% to $25.6 million in 2024, then retreated by 21.3% to $20.2 million in 2025.
- The last three Total Non-Current Liabilities figures came in at $20.2 million (Q4 2025), $20.5 million (Q3 2025), and $22.2 million (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | 18.28 Bn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | 11.64 Bn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | 599.10 Mn |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | 44.12 Mn |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | 1.24 Bn |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | 6.26 Bn |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | 2.44 Bn |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | 1.13 Bn |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | 1.81 Bn |
| 10 | Rockwell Medical | 26.01 Mn | 2.12 Mn | 2.90 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 20.16 Mn |
| Sep 30, 2025 | 20.47 Mn |
| Jun 30, 2025 | 22.22 Mn |
| Mar 31, 2025 | 19.54 Mn |
| Dec 31, 2024 | 25.62 Mn |
| Sep 30, 2024 | 26.20 Mn |
| Jun 30, 2024 | 29.52 Mn |
| Mar 31, 2024 | 27.58 Mn |
| Dec 31, 2023 | 30.87 Mn |
| Sep 30, 2023 | 28.59 Mn |
| Jun 30, 2023 | 28.50 Mn |
| Mar 31, 2023 | 27.92 Mn |
| Dec 31, 2022 | 32.52 Mn |
| Sep 30, 2022 | 38.04 Mn |
| Jun 30, 2022 | 38.96 Mn |
| Mar 31, 2022 | 42.23 Mn |
| Dec 31, 2021 | 46.03 Mn |
| Dec 31, 2020 | 43.58 Mn |
| Sep 30, 2014 | 25.11 Mn |
| Jun 30, 2014 | 25.57 Mn |